I predict that VEGF-Trap-Eye will be a commercial bust
What's your definition of commercial bust? You think REGN/Bayer's drug at peak can't get 20% of Lucentis worldwide sales? 20% off current Lucentis sale is $600m/year.
Despite supposed off-label usage of Avastin, Lucentis sales have continued to rise quite rapidly.